BPL-003 is a novel, nasal spray formulation of mebufotenin benzoate designed to deliver rapid and durable antidepressant effects from a single dose.
The FDA approved Amgen's and AstraZeneca's drug to treat chronic rhinosinusitis with nasal polyps, an inflammatory condition of the sinuses and nasal passages. The companies said the approval was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback